Skip to content

Intelligent Needle Tip Tracking Using Ultrasound Imaging for Infraclavicular Brachial Plexus Blocks

Intelligent Needle Tip Tracking Using Ultrasound Imaging for Infraclavicular Brachial Plexus Blocks

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03631914
Enrollment
26
Registered
2018-08-15
Start date
2018-09-03
Completion date
2018-10-01
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Block

Brief summary

In a randomized controlled crossover study design, ultrasound guided infraclavicular brachial plexus blocks will be performed with and without the aid of a needle tip tracking (NTT) system. Specialists in anaesthesiology with average experience in ultrasound guided PNB techniques will perform the blocks. 26 volunteers will be included. The primary objective is to investigate the effect of the NTT system on performance time, as a measure for improved block performance. Secondary objectives are the effects of the NTT system on dexterity, peripheral nerve block characteristics, subjective experience, and peripheral block performance.

Interventions

An infraclavicular brachial plexus block is performed using ultrasound guidance.

Sponsors

Philips Medical Systems
CollaboratorINDUSTRY
B. Braun Melsungen AG
CollaboratorINDUSTRY
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ASA physical status 1 or 2 * Volunteers that have given informed written consent

Exclusion criteria

* BMI \< 18 kg/m2 * BMI \> 35 kg/m2 * Body weight \> 95 kg * Volunteers that cannot cooperate during the examination * Volunteers that do not speak or understand Norwegian language * Volunteers with neurologic disease, nerve- or vascular impairment * Volunteers with known coagulopathy * Volunteers that are allergic to Lidocaine or other local anaesthetic agents * Medications at the investigators discretion * Volunteers with concomitant medical treatments interfering with PNB treatment * Skin disease or infection affecting the whole-body surface or within the area of examination * Any reason why, in the opinion of the investigators, the volunteer should not participate * Subject participates in a potentially confounding drug or device trial during the course of the study * Pregnancy and lactation period * Women of childbearing potential who do not use an effective and secure method for birth control

Design outcomes

Primary

MeasureTime frameDescription
Performance timeDuring peripheral nerve block procedurePerformance time is defined as the time from insertion of the block needle (skin puncture) until finishing LA injection

Secondary

MeasureTime frameDescription
Distance travelled by probe handDuring peripheral nerve block procedureMeasured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection
Number of intended movements (needling hand)During peripheral nerve block procedureMeasured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection
Number of intended movements (probe hand)During peripheral nerve block procedureMeasured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection
Block success30 minutes after peripheral nerve block procedureA sensory block is defined as successful when there is analgesia (no sensation for touch) or anaesthesia (no sensation at all) involving all five nerves distal to the elbow
Distance travelled by needling handDuring peripheral nerve block procedureMeasured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection
Block durationWithin 240 minutes after peripheral nerve block procedureBlock duration is the time from the end of LA injection until at least one of the nerves involved in the sensory block has recovered
Quantified discomfort during block performanceImmediately after peripheral nerve block procedureThe participants are asked about discomfort during the block procedure using a numeric rating scale (scale range 0 - 10; 0 = no discomfort; 10 = worst discomfort imaginable)
Confidence in block successImmediately after peripheral nerve block procedureThe anaesthetist is asked if he expects the block to be successful using a numeric rating scale (scale range 0 - 10; 0 = block success unlikely; 10 = block success very likely)
Block onset timeWithin 60 minutes after peripheral nerve block procedureBlock onset time is defined as the time between the end of LA injection and development of a successful sensory block

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026